Conference call will be held on Thursday, May 9 at 9:00 AM
ET
CARMEL,
Ind., May 1, 2024 /PRNewswire/ -- Syra Health
Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a
healthcare technology company with a mission to improve healthcare
by providing innovative services and technology solutions,
announced today that it will report financial results for its first
quarter 2024 ended March 31, 2024, on Thursday, May 9,
2024, before the market opens. The Company has scheduled a
conference call that same day, May 9, 2024, at 9:00 a.m.
ET, to review the results.
Interested parties can access the conference call via Internet
webcast, which is available in the Investors section of
the Company's website at
https://ir.syrahealth.com/presentations/q1-2024-earnings-call.
Investors who would like to submit a question to be addressed on
the call should email the question to
shamsian@lythampartners.com.
A webcast replay will be available in the Investors section of
the Company's website at
https://ir.syrahealth.com/presentations/q1-2024-earnings-call.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some
of healthcare's most significant challenges in areas such
as behavioral and mental health, digital health,
and population health, by providing innovative services and
technology solutions. Syra Health's products and services are
centered on prevention, improved access, and affordable care. Syra
Health supplies its solutions to payers, providers, life sciences
organizations, academic institutions, and government. For more
information, please visit www.syrahealth.com.
For more information, please contact:
For Media Inquiries:
Christine
Drury
Communications and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben
Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syra-health-to-discuss-first-quarter-2024-financial-results-302132941.html
SOURCE Syra Health
